What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

Kaiku Health receives Digi-HTA recommendation

Kaiku Health, the developer of digital health intervention platform in oncology, has received the Digi-HTA recommendation of use. The Digi-HTA is a criteria tool for assessing digital healthcare services’ (eg. mobile apps, AI solutions, and robotics) suitability for use in healthcare. The recommendation states that:  “The Kaiku Health service is suitable for monitoring the well-being...

Read the article

Increasing the understanding behind treatment response and immune-related adverse events in cancer patients treated with immune checkpoint inhibitor therapies

Increasing the understanding behind treatment response and immune-related adverse events in cancer patients treated with immune checkpoint inhibitor therapies Kaiku Health and Oulu University Hospital (OYS) aim to increase the understanding behind treatment benefit and onset of complex immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapies. The findings from this study conducted...

Read the article

Kaiku Health strengthens oncology expertise – Mari Metso-Lintula joins as Medical Director

Kaiku Health, the developer of digital health intervention platform in oncology, adds medical expertise and years of experience in oncology and hematology with Dr. Mari Metso-Lintula joining the team as Medical Director.  Dr. Metso-Lintula is an experienced oncologist and hematologist with a background in the medical device industry and electronic patient-reported outcomes. Her responsibilities at...

Read the article

Machine learning may help to detect the onset of immune-related adverse events in cancer patients

Kaiku has continued its pioneering research and efforts to find potential ways to improve safety and quality of life of cancer patients treated with immune checkpoint inhibitor (ICI) therapies. ICIs can be associated with severe adverse events which may occur even after treatment discontinuation. Research conducted in collaboration between Kaiku Health and the Oulu University...

Read the article

Kaiku Health to present research at ESMO 2020

Kaiku Health will present two scientific abstracts at the ESMO Virtual Congress 2020. The research has been conducted in collaboration with Oulu University Hospital and it investigates combining machine learning, patient-reported symptom data and lab measurements to analyse treatment response and predict the onset of immune-related adverse events in immune checkpoint inhibitor therapies. The two...

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
ellen.nurmi@kaikuhealth.com
+358 445512744

Contact

Get in touch with us

Interested in learning more about Kaiku Health? Send us a note